AbbVie Inc.
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
ABBV$293.30+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| as of December 31 (in millions, except share data) | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and equivalents | $5,229 | $5,524 |
| Short-term investments | 28 | 31 |
| Accounts receivable, net | 12,589 | 10,919 |
| Inventories | 4,951 | 4,181 |
| Prepaid expenses and other | 6,265 | 4,927 |
| Total current assets | 29,062 | 25,582 |
| Investments | 268 | 279 |
| Property and equipment, net | 5,628 | 5,134 |
| Intangible assets, net | 52,641 | 60,068 |
| Goodwill | 35,640 | 34,956 |
| Other assets | 10,721 | 9,142 |
| Total assets | $133,960 | $135,161 |
| Liabilities and Equity | ||
| Current liabilities | ||
| Short-term borrowings | $2,499 | $— |
| Current portion of long-term debt and finance lease obligations | 6,056 | 6,804 |
| Accounts payable and accrued liabilities | 34,734 | 31,945 |
| Total current liabilities | 43,289 | 38,749 |
| Long-term debt and finance lease obligations | 58,941 | 60,340 |
| Deferred income taxes | 2,389 | 2,579 |
| Other long-term liabilities | 32,569 | 30,129 |
| Commitments and contingencies | ||
| Stockholders' equity (deficit) | ||
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,838,678,628 shares issued as of December 31, 2025 and 1,831,594,494 as of December 31, 2024 | 18 | 18 |
| Common stock held in treasury, at cost, 70,802,593 shares as of December 31, 2025 and 66,337,508 as of December 31, 2024 | (9,146) | (8,201) |
| Additional paid-in capital | 22,495 | 21,333 |
| Accumulated deficit | (15,493) | (7,900) |
| Accumulated other comprehensive loss | (1,144) | (1,925) |
| Total stockholders' equity (deficit) | (3,270) | 3,325 |
| Noncontrolling interest | 42 | 39 |
| Total equity (deficit) | (3,228) | 3,364 |
| Total liabilities and equity | $133,960 | $135,161 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.